Intuitive Surgical, Inc., the global leader in robotic-assisted surgery, reported quarterly earnings that surpassed analyst expectations, fueled by sustained growth in demand for its da Vinci surgical robot systems and related instruments. The company’s strong performance underscores the accelerating adoption of robotic surgery in hospitals worldwide.

For the reported quarter, Intuitive Surgical posted revenue of $1.9 billion, exceeding Wall Street estimates of $1.8 billion. Net income rose to $470 million, reflecting a robust increase in surgical procedure volumes and growing installations of da Vinci systems across North America, Europe, and Asia-Pacific.

The company attributed its performance to increased hospital adoption of robotic-assisted procedures, particularly in urology, gynecology, and general surgery, and expanding utilization of advanced instruments and accessories.

Chief Executive Officer of Intuitive Surgical, stated, “We continue to see strong demand for our robotic platforms as hospitals recognize the clinical benefits, precision, and patient outcomes offered by robotic-assisted surgery. Our focus remains on expanding access to these technologies while supporting surgeons and healthcare teams globally.”

Analysts note that Intuitive’s growth reflects broader trends in the healthcare sector, including minimally invasive surgery adoption, digital integration in operating rooms, and investment in advanced surgical technology. The company also highlighted ongoing initiatives in training, research, and support services, which are helping to expand the global footprint of robotic surgery.

With healthcare systems increasingly emphasizing patient safety, shorter recovery times, and efficiency, Intuitive Surgical is well-positioned to maintain its market leadership and capitalize on the growing demand for robotic-assisted surgical solutions.